Study design: Retrospective cohort study.
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Overall class of evidence III
The definiton of the different classes of evidence is available on page 67.
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STUDY RATIONALE AND CONTEXT
Prior to the widespread use of bone morphogenetic proteins (BMPs), lumbar interbody fusion augmented by posterior fixation was reported to improve patient outcome through indirect decompression of the intervertebral foramen and through increased likelihood of fusion success. These days, BMPs provide greater certainty in PL fusion, raising the question: Is there clinical value in anterior column support in low-grade spondylolisthesis?
CLINICAL QUESTION
Is there a benefit to additional transforaminal lumbar interbody fusion (TLIF) if a solid PL fusion can be achieved with routine BMP-7 use in low-grade spondylolisthesis?
METHODS
Study design:
A retrospective single-hospital, singlesurgeon cohort of patients treated for grade I or II spondylolisthesis by PL fusion with BMP-7 with or without TLIF and anterior BMP-7.
Inclusion criteria: Patients with grade I or II spondylolisthesis, PL grafting with BMP-7, aged between 30 and 90 years. Exclusion criteria (Fig 1) : high-grade spondylolisthesis (grade III or IV), isthmic spondylolisthesis, dysplastic spondylolisthesis, previous lumbar spine surgery, patient taking steroids, patient receiving chemotherapy, smokers (in the previous 6 months). (Fig 1) PL fusion with local autograft and BMP-7 representing a change in preference by the treating surgeon were available for follow-up.
Patient population and interventions compared
• The overall follow-up rate was 89%.
• Assessment was performed unblinded to the modality of treatment.
• Complications were assessed as either major, requiring immediate additional intervention (eg, postoperative leg pain, adjacent segment symptoms requiring surgery, or postoperative infection requiring washout), or minor, requiring observation only (eg, dural tear or adjacent segment symptoms not requiring surgery). 
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Outcomes:
• The Oswestry Disability Index (ODI) was recorded preoperatively, at 3 months of care, as is standard, and ODI was collected by telephone interview approximately 12 months postoperatively.
• Posterior fusion was assessed using the Lenke classification [1] .
• Anterior fusion was assessed using the modified criteria of Lee et al [2] .
• Intraoperative and postoperative complications were recorded in both groups.
Analysis:
• Fisher exact test was used to compare groups on the following outcomes: (1) the proportion of patients who improved a minimum clinically significant difference of 12.8% ODI at the various time points; (2), proportion of patients with successful fusion; and (3) proportion of patients with complications [3] .
Additional methodological and technical details are provided in the Web Appendix at www.aospineorg/ebsj.
RESULTS
• Figure 1 indicates the number of patients in each group. 
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DISCUSSION
• Of various surgical techniques for spondylolisthesis, TLIF is gaining popularity; although technically more challenging, as it involves circumferential fusion and restores disc height.
• Experimentally, 360° fusion has been shown to provide significant biomechanical stability over isolated posterior fusion [4] . In our study, there was no significant difference in fusion rates, which may be the reason for the similar functional outcomes.
• Most studies in the past comparing PLF with PLIF for spondylolisthesis have found better functional results with PLIF [57] . This has been attributed to the additional anterior column support leading to higher-fusion rates provided by interbody fusion.
• Recombinant human BMP-7 is known to augment fusion rates in many clinical trials worldwide, although recently the safety of other BMPs, especially in anterior fusion, has been questioned [8] . This made us question the necessity of a more cumbersome and technically demanding and potentially unsafe TLIF/BMP-7 procedure over solid PL fusion with BMP-7.
• We showed that if a solid fusion can be achieved posteriorly with adjunct therapies, such as BMP-7, there is no significant difference in the results between the PLIF/PLF and the PLF-alone groups and it would seem reasonable to avoid the extra procedure and perform PLF alone.
• Strengths: Single hospital, single surgeon, similar techniques, and good follow-up.
• Limitations: The study was retrospective in design, computed tomography (CT) was not used to assess fusion status, and no clinical outcome measures were recorded in early postoperative period (ie, 1 day and 1week after surgery).
• Clinical relevance and impact: This study suggests that there may be some value in rethinking the role of primary circumferential fusion. There is a difference in the complication profile of BMP-7 and BMP-2 and as such a limitation of this study is that these results may not directly relate to the utility of BMP-2 in this application.
SUMMARY AND CONCLUSIONS
• In the presence of a solid posterior fusion, the additional support provided by an anterior fusion has no significant benefit in ODI in the mid-term to long-term.
• While there was no significant difference in complications, the study was not powered to detect this. What is important to note is that the range and severity of complications in each group are similar.
